| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.02 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.46 | 0.02 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.37 | 0.02 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |